A*STAR reports new Mpro inhibitors

Dec. 5, 2024

The Agency for Science Technology & Research (A*STAR) Bioprocessing Technology Institute has patented 3C-like proteinase (3CLpro; Mpro; nsp5) (coronavirus) inhibitors.

BioWorld Science Infection Coronavirus Patents

Today's news in brief

BioWorld

BioWorld briefs for July 2, 2025.

Today's news in brief

BioWorld MedTech

BioWorld MedTech briefs for July 2, 2025.

Unnatural Products joins Argenx in a $1.5B macrocyclic deal

BioWorld

Unnatural Products Inc. notched another collaboration by signing on with Argenx SE in a multitarget research collaboration. Unnatural Products, which is getting...

Illustration of the β2-adrenergic receptor

Exercise-mimicking compound offers alternative to GLP-1 therapies

BioWorld

An experimental drug for treating diabetes and obesity has been shown to lower blood sugar levels and increase fat burning. It is a β2-adrenergic receptor (β2AR)...

CMS eyes competitive bidding for CGMs, insulin pumps

BioWorld MedTech

The U.S. Centers for Medicare & Medicaid Services posted the draft home health rule for calendar year 2026, which includes a proposal to subject continuous...